Researchers from The Scripps Research Institute (TSRI) and PATH have shed light on how the human immune system recognizes the malaria parasite. Read more...
MVI PortfolioWe strategically use our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity.
Evaluation technology projectsWe partner to develop and optimize new assays and challenge models and support reference and service laboratories.
RTS,SGhana, Kenya, and Malawi to take part in WHO malaria vaccine pilot programme
PATH and Walter Reed Army Institute of Research announce largest-ever controlled malaria infection study
8 Sep 2017
PATH partners with the Mahidol Oxford Tropical Medicine Research Unit on first study of the RTS,S malaria vaccine in Asia
9 Aug 2017
Return on innovation: Why global health R&D is a smart investment for the United States
19 Jul 2017
Accelerating US Progress in Combating Malaria Worldwide: Recommendations for Maximizing Investments Toward a World Free From Malaria
22 Jun 2017
Radboud University Medical Center, the Instituto de Medicina Molecular, and PATH’s Malaria Vaccine Initiative will collaborate on first-in-human study of a novel malaria vaccine approach
30 May 2017
Preparing for malaria vaccines in Africa: A tool for malaria vaccine decision-making
24 Apr 2017
PATH and GSK welcome progress toward RTS,S malaria vaccine pilot implementation with selection of countries
24 Apr 2017